CircPVT1

ncRNA information

ncRNA name

CircPVT1

Specific or universal ncRNAs

Universal ncRNAs

Class

Circular RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-145-5p/ABCC1

Cancer information

Cancer name

Lung Adenocarcinoma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin/Pemetrexed

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

37

Male patients

67

Female patients

52(<63)+52(>=63)

Age range and number

Not available

Research information

PMID

Description

CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis

Tissue resource

lung adenocarcinoma and corresponding normal lung tissues

human pulmonary alveolar epithelial cell lines PAEC

human lung adenocarcinoma cell lines PC9

human lung adenocarcinoma cell lines A549

human lung adenocarcinoma drug-resistant cell lines A549/DR

Experiment

104


Institute

Shengjing Hospital

Country

China

Continent

Asia